Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Pipemidic Acid → 2-(4-{[(3-Benzothiadiazolphenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic Acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Pipemidic Acid | HCID 4831 | — |
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | 2,1,3-Benzothiadiazol-5-yl isothiocyanate | HCID 2776292 | — |
| 생성물 | 2-(4-{[(3-Benzothiadiazolphenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic Acid | HCID 45484169 | — |
반응 단계
Pipemidic acid (25 mg, 0.0824 mmol), 2,1,3-benzothiadiazol-5-yl isothiocyanate (15.8 mg, 0.0824 mmol) and triethylamine (23 μL, 0.165 mmol) were used. Purification on silica yielded compound 7 in Table 1, below (24 mg, 58%). 1H NMR (300 MHz, DMSO) δ 9.26 (s, 1H), 8.98 (s, 1H), 7.98-7.82 (m, 3H), 4.51-4.33 (m, 2H), 4.24-3.99 (m, 8H), 1.42-1.32 (m, 3H) ppm.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08497371B2 |
| 출처 데이터셋 | uspto-grants-2013_07 |
| ORD ID | ord-1055adf2670945d680d887e10525002d |
| 출처 메모 | uspto-grants-2013_07 |